The DOI matches its Crossref record; 258 of the 261 references it cites were found in a registry or an index.
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Open accessAbstract
Despite its position as the first-line drug for treatment of type 2 diabetes mellitus, the mechanisms underlying the plasma glucose level-lowering effects of metformin (1,1-dimethylbiguanide) still remain incompletely understood. Metformin is thought to exert its primary antidiabetic action through the suppression of hepatic glucose production. In addition, the discovery that metformin inhibits the mitochondrial respiratory chain complex 1 has placed energy metabolism and activation of AMP-activated protein kinase (AMPK) at the centre of its proposed mechanism of action. However, the role of AMPK has been challenged and might only account for indirect changes in hepatic insulin sensitivity. Various mechanisms involving alterations in cellular energy charge, AMP-mediated inhibition of adenylate cyclase or fructose-1,6-bisphosphatase 1 and modulation of the cellular redox state through direct inhibition of mitochondrial glycerol-3-phosphate dehydrogenase have been proposed for the acute inhibition of gluconeogenesis by metformin. Emerging evidence suggests that metformin could improve obesity-induced meta-inflammation via direct and indirect effects on tissue-resident immune cells in metabolic organs (that is, adipose tissue, the gastrointestinal tract and the liver). Furthermore, the gastrointestinal tract also has a major role in metformin action through modulation of glucose-lowering hormone glucagon-like peptide 1 and the intestinal bile acid pool and alterations in gut microbiota composition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A considerable number of studies have also found that metformin decreases fasting plasma glucose (PG) concentration and hemoglobin A1c by conserving the β-cell function or by decreasing liver glucose production (hepatic gluconeogenesis) (181–184).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [183]
Citations
Cites
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,659
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Cited by
Sorted by citations
Items 201–300 of 721
Let-7 underlies metformin-induced inhibition of hepatic glucose production
Xie, D., Chen, F., Zhang, Y., Shi, B., Song, J., Chaudhari, K., Yang, S., Zhang, G. J., Sun, X., Taylor, H. S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122217119 · Cited by 24
Ye, X., Wu, K., Xu, L., Cen, Y., Ni, J., Chen, J., Zheng, W., & Liu, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1103972 · Cited by 24
Liu, J., Zhang, M., Deng, D., & Zhu, X. M. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01445-2 · Cited by 24
Sun, M., Liu, F., Yan, P., Chen, W., & Wang, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17906 · Cited by 27
Xiao, X., Zhang, J., Ji, S., Qin, C., Wu, Y., Zou, Y., Yang, J., Zhao, Y., Yang, Q., & Liu, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1026995 · Cited by 23
Ito, J., Nogami, M., Morita, Y., Sakaguchi, K., Komada, H., Hirota, Y., Sugawara, K., Tamori, Y., Zeng, F., Murakami, T., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14262 · Cited by 23
Wang, J., Lü, Y., Min, X., Yuan, T., Wei, J., & Cai, Z. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.648212 · Cited by 23
Giusti, L., Tesi, M., Ciregia, F., Marselli, L., Zallocco, L., Suleiman, M., Luca, C. D., Guerra, S. D., Zuccarini, M., Trerotola, M., et al. (2022) · Cells · doi:10.3390/cells11152465 · Cited by 22
Barros, S., Alves, N., Pinheiro, M., Ribeiro, M., Morais, H., Montes, R., Rodil, R., Quintana, J. B., Coimbra, A. M., Santos, M. M., et al. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.2c05719 · Cited by 22
Stimulatory effect of imeglimin on incretin secretion
Yingyue, Q., Sugawara, K., Takahashi, H., Yokoi, N., Ohbayashi, K., Iwasaki, Y., Seino, S., & Ogawa, W. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14001 · Cited by 22
Jiang, S., Yuan, T., Rosenberger, F. A., Mourier, A., Dragano, N. R. V., Kremer, L. S., Rubalcava-Gracia, D., Hansen, F. M., Borg, M. L., Mennuni, M., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01038-3 · Cited by 22
Olson, N. C., Doyle, M. F., Sitlani, C. M., de Boer, I. H., Rich, S. S., Huber, S. A., LANDAY, A. L., Tracy, R. P., Psaty, B. M., & Delaney, J. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa036 · Cited by 22
Su, S., Chien, C., Chen, Y., Chiang, C., Lin, F., Kuo, F., Huang, C., Li, P., Liu, J., Lu, C., et al. (2022) · BioFactors · doi:10.1002/biof.1872 · Cited by 22
Pal, R. S., Jawaid, T., Rahman, M. A., Verma, R. K., Patra, P. K., Vijaypal, S. V., Pal, Y., & Upadhyay, R. (2025) · Biochimie · doi:10.1016/j.biochi.2025.03.002 · Cited by 21
Hu, Y., Lu, S., Xue, C., Hu, Z., Wang, Y., Zhang, W., Wang, J., Wang, J., Ding, G., Hu, Y., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06357-x · Cited by 21
Metabolic Homeostasis of Immune Cells Modulates Cardiovascular Diseases
Li, M., Sun, X., Zeng, L., Sun, A., & Ge, J. (2025) · Research · doi:10.34133/research.0679 · Cited by 20
The Future of Metformin in the Prevention of Diabetes-Related Osteoporosis
Aung, M., Amin, S., Gulraiz, A., Gandhi, F. R., Escobar, J. A. P., & Malik, B. H. (2020) · Cureus · doi:10.7759/cureus.10412 · Cited by 21
Greabu, M., Bădoiu, S. C., Stănescu-Spînu, I.-I., Miricescu, D., Totan, A., Badoiu, S. E., Costagliola, M., & Jinga, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189782 · Cited by 21
Mechanism Underlying Metformin Action and Its Potential to Reduce Gastric Cancer Risk
Lan, W.-H., Lin, T., Yeh, J.-A., Feng, C., Hsu, J., Lin, H., Kuo, C., & Lai, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214163 · Cited by 21
Scontri, C. M. C. B., Magalhães, F. D. C., Damiani, A. P. M., Hamblin, M. R., Zamunér, A. R., & Ferraresi, C. (2023) · Journal of Biophotonics · doi:10.1002/jbio.202300083 · Cited by 21
Ruiz‐Mitjana, A., Vidal‐Sabanés, M., Navaridas, R., Perramon‐Güell, A., Yeramian, A., Nicholson-Sabaté, N., Egea, J., Encinas, M., Matías‐Guiu, X., & Dolcet, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115817 · Cited by 21
Dong, L., Li, S., Huang, J., Li, W., & Ali, M. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.171108 · Cited by 21
Type 2 Innate Lymphoid Cells: Protectors in Type 2 Diabetes
Painter, J. D., & Akbari, O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.727008 · Cited by 21
Editorial: Metformin: Beyond Diabetes
Bost, F., Rena, G., & Viollet, B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00851 · Cited by 21
Self-citationGuo, X., Su, Y. B., Du, Y., Zhang, F., Yu, W., Ren, W.-C., Li, S., Kuang, H., & Wu, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.139514 · Cited by 20
Suzuki, H., Hasegawa, S., Fushimi, S., Tagami, K., Nishikawa, M., Kondo, Y., & Yasuda, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-93647-5 · Cited by 20
Lee, J., Lee, J. K., Lee, J., Park, S., Jung, S., Lee, H., & Ha, J. (2022) · Journal of Medicinal Food · doi:10.1089/jmf.2022.k.0019 · Cited by 20
Polystyrene microplastics mitigate the embryotoxic damage of metformin and guanylurea in Danio rerio
Elizalde-Velázquez, G. A., Gómez‐Oliván, L. M., García-Medina, S., Hernández-Díaz, M., Islas‐Flores, H., Galar‐Martínez, M., García-Medina, A. L., Chanona‐Pérez, J. J., & Hernández‐Varela, J. D. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.158503 · Cited by 20
Chuang, H., Chan, H., & Shih, K. (2024) · BioFactors · doi:10.1002/biof.2137 · Cited by 20
Impact of metformin on immunological markers: Implication in its anti-tumor mechanism
Chen, G. G., Woo, P. Y., Ng, S. C. P., Wong, G. K. C., Chan, D. T.-M., van Hasselt, C. A., Tong, M. C. F., & Poon, W. S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107585 · Cited by 20
Fuentes-Barría, H., Aguilera-Eguía, R. A., Flores-Fernández, C., Angarita, L., & Alarcón-Rivera, M. (2026) · Biomedicines · doi:10.3390/biomedicines14040752 · Cited by 19
Nasykhova, Y. A., Barbitoff, Y. A., Tonyan, Z. N., Danilova, M. M., Nevzorov, I. A., Komandresova, T. M., Mikhailova, A. A., Vasilieva, T., Glavnova, O. B., Yarmolinskaya, M. I., et al. (2022) · Genes · doi:10.3390/genes13081310 · Cited by 19
The anti-diabetic effects of metformin are mediated by regulating long non-coding RNA
Chang, W., Li, W., & Li, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1256705 · Cited by 19
Al-kofahi, T., Al‐Trad, B., Amawi, H. A., Aljabali, A. A. A., Abul‐Haija, Y. M., & Obeid, M. A. (2024) · Therapeutic Delivery · doi:10.4155/tde-2023-0089 · Cited by 19
Bioinformatics analysis of gene and microRNA targets for fibromyalgia
Qiu, Y., Zhang, T., Meng, L., Cheng, X.-T., & Hua, Z. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/iitbcp · Cited by 19
Gedawy, A., Al‐Salami, H., & Dass, C. R. (2020) · Therapeutic Delivery · doi:10.4155/tde-2020-0102 · Cited by 19
Luo, G., Zhou, Z., Li, C., Zhang, P., Chen, W., Li, X., Tang, J., & Qing, L. (2023) · Research Square · doi:10.21203/rs.3.rs-2700955/v1 · Cited by 19
Mohamed, S. (2024) · Medicine · doi:10.1097/md.0000000000040221 · Cited by 20
Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
Thomas, C., Wurzer, L., Malle, E., Ristow, M., & Madreiter‐Sokolowski, C. T. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.905261 · Cited by 18
Zhang, Y.-H., Jiao, X., Liu, J., Feng, G. L., Luo, X., Zhang, M., Zhang, B., Huang, L.-Z., & Long, Q. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117484 · Cited by 18
Song, X., Zhao, M.-N., Li, G., Li, N., Wang, T. Z., & Zhou, H. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i12.1849 · Cited by 18
Deng, A., Wang, Y., Huang, K., Xie, P., Mo, P., Liu, F., Chen, J., Chen, K., Wang, Y., & Xiao, B. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04275-3 · Cited by 19
Metformin in gestational diabetes: physiological actions and clinical applications
Mason, T., Alesi, S., Fernando, M., Vanky, E., Teede, H. J., & Mousa, A. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01049-w · Cited by 19
Bairwa, G., Sánchez‐León, E., Do, E., Jung, W. H., & Kronstad, J. W. (2020) · mBio · doi:10.1128/mbio.00986-20 · Cited by 18
New Horizons in Microbiota and Metabolic Health Research
Mishra, S. P., Jain, S., Taraphder, S., & Yadav, H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa769 · Cited by 18
Poly, T. N., Islam, M. M., Li, Y., Lin, M., Hsu, M., & Wang, Y. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163507 · Cited by 18
Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?
Marini, C., Cossu, V., Bauckneht, M., Lanfranchi, F., Raffa, S., Orengo, A. M., Ravera, S., Bruno, S., & Sambuceti, G. (2021) · Biomolecules · doi:10.3390/biom11081231 · Cited by 18
Metformin treatment of juvenile mice alters aging-related developmental and metabolic phenotypes
Zhu, Y. X., Fang, Y., Medina, D., Bartke, A., & Yuan, R. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111597 · Cited by 18
High Mobility Group Proteins in Sepsis
Liang, G.-B., & He, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.911152 · Cited by 18
Cui, L., Song, Y., Hou, Z., Yang, L., Guo, S., & Wang, C. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03461-4 · Cited by 18
Metformin and Adipose Tissue: A Multifaceted Regulator in Metabolism, Inflammation, and Regeneration
Wei, X.-L., Tao, M., Li, R.-H., Ge, S.-H., & Xiao, W. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2025.2371 · Cited by 17
Morrison, K. R., Wang, T., Chan, K. Y., Trotter, E. W., Gillespie, A., Michael, M., Oakhill, J. S., Hagan, I., & Petersen, J. (2023) · Open Biology · doi:10.1098/rsob.230021 · Cited by 17
Wang, Y., Yu, F., Zheng, X., Li, J., Zhang, Z., Zhang, Q., Chen, J., He, Y., Yang, H., & Zhou, P. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01880-6 · Cited by 17
Wei, M., Wang, L., Liu, X., Deng, Y., Yang, S., Pan, W., Zhang, X., Xu, G., Xiao, S., & Deng, C. (2024) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000011363 · Cited by 17
Gong, P., Wang, J., Wang, S., Yang, W., Yao, W., Li, N., Wang, J., Zhao, Y., Chen, F., Xie, J., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155546 · Cited by 17
Lipotoxicity: The missing link between diabetes and periodontitis?
Sun, Y. L., Yin, Y., Yang, S., Ai, D., Qin, H., Xia, X., Xu, X., & Song, J. (2024) · Journal of Periodontal Research · doi:10.1111/jre.13242 · Cited by 17
Chai, X., Wang, Y., Yin, X., Gong, Q., Zhang, J., Shao, R., & Li, G. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103184 · Cited by 17
Jin, W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00613 · Cited by 17
Ren, Y.-R., Ye, Y., Feng, Y., Xu, T., Shen, Y., Liu, J., Huang, S., Shen, J., & Leng, Y. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00609-w · Cited by 17
Metformin: Expanding the Scope of Application—Starting Earlier than Yesterday, Canceling Later
Kononova, Y. A., Likhonosov, N. P., & Babenko, A. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042363 · Cited by 17
Factors That Contribute to hIAPP Amyloidosis in Type 2 Diabetes Mellitus
Sevcuka, A., White, K., & Terry, C. (2022) · Life · doi:10.3390/life12040583 · Cited by 17
Zhang, B., Jin, Z., Zhai, T., Ding, Q., Yang, H., Wang, J., Zhang, L., & Zhao, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1011050 · Cited by 17
Cravalho, C. K. L., Meyers, A. G., Mabundo, L. S., Courville, A. B., Yang, S. B., Cai, H., Dai, Y., Walter, M. F., Walter, P. J., Sharma, S., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05236-y · Cited by 17
A new insight into cell biological and biochemical changes through aging
Sahabi, S., Jafari-Gharabaghlou, D., & Zarghami, N. (2022) · Acta Histochemica · doi:10.1016/j.acthis.2021.151841 · Cited by 16
Taher, H., Sabra, M. S., Salah-Eldin, A.-E., & Sayed, A. E. H. (2022) · Toxicology and Environmental Health Sciences · doi:10.1007/s13530-022-00150-9 · Cited by 16
AlZaim, I., Eid, A. H., Abd‐Elrahman, K. S., & EL‐Yazbi, A. F. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115337 · Cited by 16
Xie, Y., Zhou, Q., He, Q., Wang, X., & Wang, J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.008 · Cited by 16
The Link between Diabetes, Pancreatic Tumors, and miRNAs—New Players for Diagnosis and Therapy?
Kozłowska, M., & Śliwińska, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210252 · Cited by 16
N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism
Zhang, H., Gu, Y., Gang, Q., Huang, J., Xiao, Q., & Ha, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1166756 · Cited by 16
Dai, H., Hou, T., Wang, Q., Zhu, Z., Zhu, Y., Zhao, Z., Li, M., Xu, Y., Lu, J., Wang, T., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15310 · Cited by 16
An apprise on novel drug delivery systems for management of diabetes mellitus
Pardhi, E. R., Bhor, Y., Singh, P. K., & Mehra, N. K. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105473 · Cited by 16
Papini, N., Giussani, P., & Tringali, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168884 · Cited by 16
Khodaei, F., Hosseini, S. M., Omidi, M., Hosseini, S. F., & Rezaei, M. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22662 · Cited by 16
Yang, Y., & Wang, Q. (2023) · Scientific Reports · doi:10.1038/s41598-023-35908-9 · Cited by 16
Wang, L., Wu, Z., Chen, X., Bai, J., Li, W., Ge, G., Zhang, W., Li, W., Qin, Y., Zhao, G., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102162 · Cited by 15
From Diabetes to Degenerative Diseases: The Multifaceted Action of Metformin
Campagnoli, L. I. M., Varesi, A., Fahmideh, F., Hakimizad, R., Petkovic, P., Barbieri, A., Marchesi, N., & Pascale, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199748 · Cited by 15
Metformin—mechanisms of its glycemia-reducing effect
Drewe, J., Foretz, M., & Krähenbühl, S. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100106 · Cited by 18
Self-citationWang, W.-H., Chen, S.-K., Huang, H., & Juan, H. (2021) · ACS Omega · doi:10.1021/acsomega.1c00894 · Cited by 15
Qi, Z., Song, N., Wang, S.-Q., Wang, Y., Zhao, Y.-K., & Zhu, X.-D. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9922292 · Cited by 15
Metformin Triggers Apoptosis and Induction of the G0/G1 Switch 2 Gene in Macrophages
Hu, X., Luo, H., Dou, C., Chen, X., Huang, Y., Wang, L., Xue, S., Sun, Z., Chen, S., Xu, Q., et al. (2021) · Genes · doi:10.3390/genes12091437 · Cited by 15
Shoaib, M., Choudhary, R. C., Kumar, R., Kim, N., Miyara, S. J., Haque, S., Yin, T., Frankfurt, M., Molmenti, E. P., Zanos, S. P., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200121r · Cited by 15
Pradhan, T., Gupta, O., Kumar, V., Sristi, & Chawla, G. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200452 · Cited by 15
Koia, J. H., & Shepherd, P. R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00935 · Cited by 15
Metformin Effects on SHIP2, AMPKs and Gut Microbiota: Recent Updates on Pharmacology
Shivaprakash, P., Beeraka, N. M., Madhunapantula, S. V., Nikolenko, V. N., & Basalingappa, K. M. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673289342240213040144 · Cited by 14
González-Casanova, J. E., Navarro-Márquez, M., Saez-Tamayo, T., Angarita, L., Durán‐Agüero, S., Fuentes-Barría, H., Bermúdez, V., & Rojas-Gómez, D. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083690 · Cited by 14
Strength exercise reduces hepatic pyruvate carboxylase and gluconeogenesis in DIO mice
Pereira, R. M., Rodrigues, K. C. D. C., Sant’Ana, M. R., Peruca, G. F., Morelli, A. P., Simabuco, F. M., da Silva, A. S. R., Cintra, D. E., Ropelle, E. R., Pauli, J. R., et al. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0193 · Cited by 14
Wu, X., Xiao, X., Chen, X., Yang, M., Hu, Z., Shuai, S., Fu, Q., Yang, H., & Du, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.948101 · Cited by 14
Striking a gut–liver balance for the antidiabetic effects of metformin
Barroso, E., Montori-Grau, M., Wahli, W., Palomer, X., & Vázquez‐Carrera, M. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.04.004 · Cited by 14
Kang, L., Yi, J., Lau, C., He, L., Chen, Q., Xu, S., Li, J., Xia, Y. Y., Zhang, Y., Huang, Y., et al. (2023) · Antioxidants · doi:10.3390/antiox12091681 · Cited by 14
Metabolomics in diabetes mellitus: clinical insight
Aleidi, S. M., Fahmawi, H. A., Masood, A., & Rahman, A. M. A. (2023) · Expert Review of Proteomics · doi:10.1080/14789450.2023.2295866 · Cited by 13
The Role and Mechanism of Metformin in the Treatment of Nervous System Diseases
Li, H., Liu, R., Liu, J., & Qu, Y. (2024) · Biomolecules · doi:10.3390/biom14121579 · Cited by 14
Feng, S., Wang, J., Peng, Q., Zhang, P., Jiang, Y., Zhang, H., Song, X., Li, Y., Huang, W., Zhang, D., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156348 · Cited by 13
Low-dose metformin requires brain Rap1 for its antidiabetic action
Lin, H., Lu, W., He, Y., Fu, Y., Kaneko, K., Huang, P., la Puente-Gomez, A. B. D., Wang, C., Yang, Y., Li, F., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu3700 · Cited by 13
Metformin use in prediabetes: is earlier intervention better?
Warrilow, A., Somerset, S. M., Pumpa, K. L., & Fleet, R. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01559-9 · Cited by 13
Chemosensing in enteroendocrine cells: mechanisms and therapeutic opportunities
Yang, M. H., Reimann, F. M., & Gribble, F. M. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000614 · Cited by 13
Metformin impairs bile acid homeostasis in ethinylestradiol-induced cholestasis in mice
Faradonbeh, F. A., Igreja, I. C., Laštůvková, H., Cermanová, J., Hroch, M., Faistova, H., Mokrý, J., Nová, Z., Uher, M., Nachtigal, P., et al. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109525 · Cited by 13
Cui, J., Song, L., Wang, R., Hu, S., Yang, Z., Zhang, Z., Sun, B., & Cui, W. (2021) · Nutrients · doi:10.3390/nu13103417 · Cited by 13
Wang, K., Lin, L., Jin, J., An, Y., Wang, Z., Zhou, S., Zhang, J., Abuduaini, B., Cheng, C., & Li, N. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108159 · Cited by 13
Gorbatenko, V. O., Goriainov, S. V., Babenko, V. A., Plotnikov, E. Y., Sergeeva, M. G., & Chistyakov, D. V. (2022) · Biochemistry (Moscow) · doi:10.1134/s000629792207001x · Cited by 13
Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis
Zhao, Z., He, X., & Sun, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1193610 · Cited by 14
Metadata
- Authors
- Foretz, M., Guigas, B., & Viollet, B.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Leiden University Medical Center (NL)
- Venue
- Nature Reviews Endocrinology
- Published
- 2019-08-22
- Volume
- 15
- Issue
- 10
- Pages
- 569-589
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2969928163
- Cited by
- 686
- References
- 261
- Citations by year
- 2026: 80 · 2025: 104 · 2024: 92 · 2023: 122 · 2022: 113 · 2021: 102 · 2020: 68 · 2019: 5
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- green
- inserm.hal.science
- Licence
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- metformin, type 2 diabetes, glucoregulation, hepatic glucose production, gluconeogenesis, AMPK, mitochondrial complex I inhibition, hepatic insulin sensitivity, adenylate cyclase inhibition, FBP1, glycerol-3-phosphate dehydrogenase, redox state, meta-inflammation, obesity, gut microbiota, glucagon-like peptide-1, bile acids
- MeSH terms
- Gastrointestinal Microbiome, Animals, Diabetes Mellitus, Type 2, Electron Transport, Glucose, Humans, Hypoglycemic Agents, Metformin, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review